Extended treatment for cigarette smoking cessation: a randomized control trial.
Extended treatment for cigarette smoking cessation: a randomized control trial.
复制标题
戒烟的延长治疗:一项随机对照试验。
DOI:
10.1111/add.13806
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
David,SeanP
中科院分区:
文献类型:
--
作者:
Laude,JenniferR;Bailey,SteffaniR;Crew,Erin;Varady,Ann;Lembke,Anna;McFall,Danielle;Jeon,Anna;Killen,Diana;Killen,JoelD;David,SeanP
AimTo test the potential benefit of extending cognitive–behavioral therapy (CBT) relative to not extending CBT on long‐term abstinence from smoking.DesignTwo‐group parallel randomized controlled trial. Patients were randomized to receive non‐extended CBT (n= 111) or extended CBT (n= 112) following a 26‐week open‐label treatment.SettingCommunity clinic in the United States.ParticipantsA total of 219 smokers (mean age: 43 years; mean cigarettes/day: 18).InterventionAll participants received 10 weeks of combined CBT + bupropion sustained release (bupropion SR) + nicotine patch and were continued on CBT and either no medications if abstinent, continued bupropion + nicotine replacement therapy (NRT) if increased craving or depression scores, or varenicline if still smoking at 10 weeks. Half the participants were randomized at 26 weeks to extended CBT (E‐CBT) to week 48 and half to non‐extended CBT (no additional CBT sessions).MeasurementsThe primary outcome was expired CO‐confirmed, 7‐day point‐prevalence (PP) at 52‐ and 104‐week follow‐up. Analyses were based on intention‐to‐treat.FindingsPP abstinence rates at the 52‐week follow‐up were comparable across non‐extended CBT (40%) and E‐CBT (39%) groups [odds ratio (OR) = 0.99; 95% confidence interval (CI) = 0.55, 1.78]. A similar pattern was observed across non‐extended CBT (39%) and E‐CBT (33%) groups at the 104‐week follow‐up (OR = 0.79; 95% CI= 0.44, 1.40).ConclusionProlonging cognitive–behavioral therapy from 26 to 48 weeks does not appear to improve long‐term abstinence from smoking.